Distinct role of ShcC docking protein in the differentiation of neuroblastoma

Oncogene

Volumn 28, Issue 5, 2009, Pages 662-673

  Miyake, I ^a   Ohira, M ^b   Nakagawara, A ^b   Sakai, R ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b CHIBA CANCER CENTER   (Japan)

Author keywords

Differentiation; ERK; Neuroblastoma; RNAi; Shc family

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN SHC; PROTEIN SHCA; PROTEIN SHCC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUDE MOUSE; ONCOGENE C MYB; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RNA INTERFERENCE; SCHOOL CHILD; SIGNAL TRANSDUCTION;

BRAIN NEOPLASMS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFANT; NEURITES; NEUROBLASTOMA; PHOSPHORYLATION; PROGNOSIS; PROTEIN-TYROSINE KINASES; RISK FACTORS; RNA, SMALL INTERFERING; SHC SIGNALING ADAPTOR PROTEINS;

MUS MUSCULUS;

EID: 59649119452     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.413     Document Type: Article

References (39)

1. Berwanger B, Hartmann O, Bergmann E, Bernard S, Nielsen D, Krause M et al. (2002). Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell 2: 377-386.
2. Brodeur GM, Nakagawara A. (1992). Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 14: 111-116.
3. Brouns MR, Matheson SF, Hu KQ, Delalle I, Caviness VS, Silver J et al. (2000). The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development. Development 127: 4891-4903.
4. Brouns MR, Matheson SF, Settleman J. (2001). p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat Cell Biol 3: 361-367.
5. Dhillon AS, Meikle S, Peyssonnaux C, Grindlay J, Kaiser C, Steen H et al. (2003). A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation. Mol Cell Biol 23: 1983-1993.
6. Giudici AM, Sher E, Pelagi M, Clementi F, Zanini A. (1992). Immunolocalization of secretogranin II, chromogranin A, and chromogranin B in differentiating human neuroblastoma cells. Eur J Cell Biol 58: 383-389.
7. Hecht M, Papoutsi M, Tran HD, Wilting J, Schweigerer L. (2004). Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res 64: 6109-6118.
8. Hecker TP, Grammer JR, Gillespie GY, Stewart Jr J, Gladson CL. (2002). Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res 62: 2699-2707.
9. Hinsby AM, Lundfald L, Ditlevsen DK, Korshunova I, Juhl L, Meakin SO et al. (2004). ShcA regulates neurite outgrowth stimulated by neural cell adhesion molecule but not by fibroblast growth factor 2: evidence for a distinct fibroblast growth factor receptor response to neural cell adhesion molecule activation. J Neurochem 91: 694-703.
10. Iwamoto T, Taniguchi M, Wajjwalku W, Nakashima I, Takahashi M. (1993). Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene. Br J Cancer 67: 504-507.
11. Leevers SJ, Paterson HF, Marshall CJ. (1994). Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411-414.
12. Liu HY, Meakin SO. (2002). ShcB and ShcC activation by the Trk family of receptor tyrosine kinases. J Biol Chem 277: 26046-26056.
13. Magrassi L, Conti L, Lanterna A, Zuccato C, Marchionni M, Cassini P et al. (2005). Shc3 affects human high-grade astrocytomas survival. Oncogene 24: 5198-5206.
14. Marshall GM, Peaston AE, Hocker JE, Smith SA, Hansford LM, Tobias V et al. (1997). Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates Jun kinase. Cancer Res 57: 5399-5405.
15. Miyake I, Hakomori Y, Misu Y, Nakadate H, Matsuura N, Sakamoto Met al. (2005). Domain-specific function of ShcC docking protein in neuroblastoma cells. Oncogene 24: 3206-3215.
16. Miyake I, Hakomori Y, Shinohara A, Gamou T, Saito M, Iwamatsu A et al. (2002). Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines. Oncogene 21: 5823-5834.
17. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L et al. (1998). Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 17: 6622-6632.
18. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. (1993). Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854.
19. Nakagawara A, Brodeur GM. (1997). Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer 33: 2050-2053.
20. Nakamura T, Komiya M, Gotoh N, Koizumi S, Shibuya M, Mori N. (2002). Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules. Oncogene 21: 22-31.
21. Nakamura T, Muraoka S, Sanokawa R, Mori N. (1998). N-Shc and Sck, two neuronally expressed Shc adapter homologs. Their differential regional expression in the brain and roles in neurotrophin and Src signaling. J Biol Chem 273: 6960-6967.
22. Nakamura T, Sanokawa R, Sasaki Y, Ayusawa D, Oishi M, Mori N. (1996). N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Oncogene 13: 1111-1121.
23. O'Bryan JP, Lambert QT, Der CJ. (1998). The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor. J Biol Chem 273: 20431-20437.
24. O'Bryan JP, Songyang Z, Cantley L, Der CJ, Pawson T. (1996). A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. Proc Natl Acad Sci USA 93: 2729-2734.
25. Ohira M, Morohashi A, Inuzuka H, Shishikura T, Kawamoto T, Kageyama H et al. (2003). Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets. Oncogene 22: 5525-5536.
26. Opel D, Poremba C, Simon T, Debatin KM, Fulda S. (2007). Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 67: 735-745.
27. Osajima-Hakomori Y, Miyake I, Ohira M, Nakagawara A, Nakagawa A, Sakai R. (2005). Biological role of anaplastic lymphoma kinase in neuroblastoma. Am J Pathol 167: 213-222.
28. Pelicci G, Dente L, De Giuseppe A, Verducci-Galletti B, Giuli S, Mele S et al. (1996). A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene 13: 633-641.
29. Qui MS, Green SH. (1992). PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9: 705-717.
30. Ravichandran KS. (2001). Signaling via Shc family adapter proteins. Oncogene 20: 6322-6330.
31. Sakai R, Henderson JT, O'Bryan JP, Elia AJ, Saxton TM, Pawson T. (2000). The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron 28: 819-833.
32. Schwab M, Westermann F, Hero B, Berthold F. (2003). Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4: 472-480.
33. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. (1994). Activation of Raf as a result of recruitment to the plasma membrane. Science 264: 1463-1467.
34. Terui E, Matsunaga T, Yoshida H, Kouchi K, Kuroda H, Hishiki T et al. (2005). Shc family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma. Clin Cancer Res 11: 3280-3287.
35. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG. (1996). The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87: 733-743.
36. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. (1998). A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625-634.
37. Wellbrock C, Weisser C, Geissinger E, Troppmair J, Schartl M. (2002). Activation of p59(Fyn) leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling. J Biol Chem 277: 6443-6454.
38. Yaka R, Gamliel A, Gurwitz D, Stein R. (1998). NGF induces transient but not sustained activation of ERK in PC12 mutant cells incapable of differentiating. J Cell Biochem 70: 425-432.
39. Yamada M, Numakawa T, Koshimizu H, Tanabe K, Wada K, Koizumi S et al. (2002). Distinct usages of phospholipase C gamma and Shc in intracellular signaling stimulated by neurotrophins. Brain Res 955: 183-190.